~~<i id='667049536E'><strike id='667049536E'><tt id='667049536E'><pre id='667049536E'></pre></tt></strike></i>~~

Home» knowledge» hotspot

hotspot

author：entertainment 2025-09-27 17:36:04 Page View：1497

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： India sets sights on home
Next article： In age of alternative facts, a scholarly course on calling out crap

leisure time

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

Biden tests positive for Covid

PresidentJoeBidenremoveshisfacemaskashearrivestospeakduringameetingwithCEOsintheWhiteHousecomplexThu

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

STAT Virtual Event: The State of Biosimilars: What to Watch

Editor’snote:Arecordingoftheeventisembeddedbelow.NowthatbiosimilarversionsofHumiraarestartingtoarriv

WSS

hotspot

hotspot

explore

leisure time

STAT Virtual Event: The State of Biosimilars: What to Watch